Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation.

Saved in:
Bibliographic Details
Title: Comparison of cisplatin-induced hearing loss in different durations of infusion and volume of hydration schedules in head and neck squamous cell carcinoma patients treated with cisplatin-based chemoradiation.
Authors: Burger AVM; Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden University, Leiden, the Netherlands., Koot MA; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands., van Balen DEM; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schaeffers AWMA; Department of Head and Neck Surgical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Zuur CL; Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Otolaryngology and Head and Neck Surgery, Leiden University Medical Center, Leiden University, Leiden, the Netherlands., Devriese LA; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Ridder M; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Hoetink AE; Department of Otorhinolaryngology-Head and Neck Surgery, University Medical Center Utrecht, UMC Brain Centre, Utrecht, the Netherlands., Schutte T; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands., Crul M; Department of Clinical Pharmacology and Pharmacy, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands. Electronic address: m.crul@amsterdamumc.nl.
Source: Oral oncology [Oral Oncol] 2025 May; Vol. 164, pp. 107246. Date of Electronic Publication: 2025 Apr 14.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first